Laboratory Medicine and Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Lung 97%
3. Mesenchymal Stem Cells 86%
4. Liver Transplantation 65%
5. Renal Cell Carcinoma 65%
6. Biopsy 47%
7. Breast Neoplasms 44%
8. Adenocarcinoma of Lung 44%
9. Cell- and Tissue-Based Therapy 41%
10. Transplants 40%
11. Allografts 40%
12. Recurrence 38%
13. Tissue Donors 36%
14. Lasers 35%
15. Polyps 33%
16. Trastuzumab 32%
17. Kidney 31%
18. Thyroid Nuclear Factor 1 31%
19. Immunohistochemistry 31%
20. Therapeutics 31%
21. Hepatitis C 30%
22. Transplant Recipients 30%
23. Staining and Labeling 29%
24. Lobular Carcinoma 28%
25. Salvage Therapy 28%
26. Eosinophilic Esophagitis 27%
27. Stem Cells 27%
28. Messenger RNA 27%
29. Proteins 26%
30. Adenocarcinoma 26%
31. Extracellular Vesicles 25%
32. Adenoma 25%
33. Survival 24%
34. Lung Neoplasms 24%
35. Squamous Cell Carcinoma 23%
36. Liver 23%
37. Neoplasm Metastasis 23%
38. Protein Kinase C 22%
39. Prostatic Neoplasms 22%
40. Genes 22%
41. Narrow Band Imaging 22%
42. Blood Component Removal 21%
43. Carcinoma 21%
44. Hepacivirus 21%
45. Radiotherapy 21%
46. Endoscopy 21%
47. Alveolar Epithelial Cells 21%
48. Barrett Esophagus 21%
49. Malignant Mesothelioma 20%
50. Infections 20%
51. Hematopoietic Stem Cells 20%
52. Safety 19%
53. Inflammation 19%
54. Ductal Carcinoma 19%
55. Lung Transplantation 18%
56. Biomarkers 18%
57. Drug Therapy 18%
58. Neuroendocrine Tumors 18%
59. Fibrosis 18%
60. T-Lymphocytes 17%
61. Colonoscopy 17%
62. Mesothelioma 17%
63. Growth 17%
64. Pathologists 16%
65. Protein Precursors 16%
66. Small Cell Lung Carcinoma 16%
67. Bronchiolitis Obliterans 15%
68. Cell Biology 15%
69. Feasibility Studies 15%
70. plerixafor octahydrochloride 15%
71. Amyloid 15%
72. Lung Diseases 15%
73. Catenins 15%
74. PKC-3 protein 14%
75. Pancreatitis 14%
76. Phenotype 14%
77. Large Cell Carcinoma 14%
78. Bone Marrow 14%
79. Pathology 14%
80. Acinar Cell Carcinoma 14%
81. TOR Serine-Threonine Kinases 14%
82. Respiratory Mucosa 13%
83. Blood Cells 13%
84. SARS Virus 13%
85. Leukapheresis 13%
86. Sirolimus 13%
87. Disease-Free Survival 13%
88. Interstitial Lung Diseases 13%
89. Oncogenes 13%
90. Metaplasia 13%
91. Tomography 13%
92. human ERBB2 protein 13%
93. Breast 13%
94. Solitary Pulmonary Nodule 13%
95. Histology 12%
96. IgA receptor 12%
97. Graft Survival 12%
98. Surface-Active Agents 12%
99. Cathepsin B 12%